Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 0.0 | BCD100322A002 | 4.6 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 0.5 | BCD100322A005 | 7.48 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 1.0 | BCD100322A009 | 4.49 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 2.0 | BCD100322A013 | 8.26 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 4.0 | BCD100322A017 | 4.45 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 8.0 | BCD100322A021 | 3.9 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 12.0 | BCD100322A025 | 4.06 | pmol/sample |
| LMFA01010017 | Margaric acid | Lipid-depleted/compactin | 24.0 | BCD100322A029 | 7.61 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 0.0 | BCD100322A001 | 2.66 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 0.5 | BCD100322A003 | 5.94 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 1.0 | BCD100322A007 | 5.79 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 2.0 | BCD100322A011 | 3.67 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 4.0 | BCD100322A015 | 4.53 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 8.0 | BCD100322A019 | 2.57 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 12.0 | BCD100322A023 | 3.9 | pmol/sample |
| LMFA01010017 | Margaric acid | C | 24.0 | BCD100322A027 | 3.93 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100322A006 | 8.36 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100322A010 | 5.89 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100322A014 | 1.19 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100322A018 | 2.01 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100322A022 | 4.68 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100322A026 | 6.42 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100322A030 | 6.95 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 0.5 | BCD100322A004 | 3.26 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 1.0 | BCD100322A008 | 5.01 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 2.0 | BCD100322A012 | 1.72 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 4.0 | BCD100322A016 | 5.66 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 8.0 | BCD100322A020 | 5.98 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 12.0 | BCD100322A024 | 3.03 | pmol/sample |
| LMFA01010017 | Margaric acid | 25OH-Chol | 24.0 | BCD100322A028 | 3.25 | pmol/sample |